Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
Holding MDGL?
Track your performance easily

Madrigal Pharmaceuticals (MDGL) Financial Statements

1,064 Followers

Madrigal Pharmaceuticals Financial Overview

Madrigal Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-25.498; its P/E ratio is -9.14; Madrigal Pharmaceuticals is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-7.05. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 14.64M----
Gross Profit$ 14.64M----
EBIT$ -148.31M$ -143.70M-$ -95.24M$ -82.90M
EBITDA$ -147.58M$ -142.88M-$ -94.43M$ -82.22M
Net Income Common Stockholders$ -151.97M$ -147.50M$ -112.19M$ -98.74M$ -85.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.06B$ 1.06B$ 634.13M$ 232.35M$ 298.42M
Total Assets$ 1.10B$ 1.08B$ 640.55M$ 237.96M$ 302.46M
Total Debt$ 118.06M$ 117.72M$ 117.19M$ 116.56M$ 99.66M
Net Debt$ -939.73M$ -941.34M$ -516.94M$ -115.79M$ -198.76M
Total Liabilities$ 242.67M$ 231.52M$ 235.21M$ 215.72M$ 198.96M
Stockholders Equity$ 857.12M$ 850.76M$ 405.33M$ 22.25M$ 103.86M
Cash Flow-
Free Cash Flow$ -140.08M$ -149.51M-$ -85.26M$ -75.38M
Operating Cash Flow$ -134.94M$ -149.16M$ -79.93M$ -84.92M$ -75.31M
Investing Cash Flow$ -122.10M$ 98.05M$ -362.12M$ 50.20M$ -3.73M
Financing Cash Flow$ 134.12M$ 573.71M$ 479.92M$ 19.58M$ 42.93M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History

Madrigal Pharmaceuticals Debt to Assets

Madrigal Pharmaceuticals Cash Flow

Madrigal Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis